Week 386 Review - Thankfully a desperate year ends slightly above the all-time low

The last trading week of 2022 only lasted a few days, and I was expecting yet another drop in portfolio value to end 2022 in an appropriately dismal manner. However, despite many shares dropping in value, a 0.5p rise in OPTI:Optibiotix was enough to improve the deficit between cost and value by £1,075 to £118,651. The total portfolio value at the end of the year is a rather pathetic £64,554. I won't be taking early retirement on that!

There were no big movers in either direction this week, so nothing really deserves Share of the Week.

No longer the lowest ever - much joy.

We're back on the trend line that we love to follow.

Here's the ISA and shares portfolio after week 22 of year 8.

			Weekly Change
Cash	£15.20		-£160.00
Portfolio cost	£82,163.25		+£160.00
Portfolio sell value (bid price-commission)	£24,721.47	(-69.9%)	+£535.91
Potential profits	£0		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.05		+£0
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£199.05	(-5.4%)	+£9.48
Total Dividends	£11,768.92		+£0
Total Interest	£0.05		+£0
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£432.50	(11.7%)	-£1.12
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

I bought 1,000 shares in SBTX:SkinBioTherapeutics at 16p with no commission as part of the retail offer. The bid price is 15p so I'm losing money on them already, but they brought down my weighted average to 37.2p instead of 47.2p. Nothing much else happened.

Same as the overall chart

Also on the trend line

The SIPP looks like this after week 370 overall and week 6 of year 8.

			Weekly Change
Cash	£344.71		-£294.40
Portfolio cost	£98,834.21		+£294.40
Portfolio sell value (bid price - commission)	£38,900.94	(-60.6%)	+£527.04
Potential profits	£343.33		+£11.93
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.01		+£0
Yr 8 Profit from sales	£94.41		+£0
Yr 8 projected avg monthly profit	£58.79	(1.2%)	-£11.76
Total Dividends	£14,142.78		+£0
Total Interest	£0.26		+£0
Total Profit from sales	£20,528.16		+£0
Average monthly cash profit	£394.24	(8.0%)	-£1.06
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

As with the ISA, I bought some SBTX:SkinBioTherapeutics shares in the retail offer. I got 1,840 at 16p for £294.40 and brought my weighted average down to 34.5p from 45.2p. Tiny increase in potential profits thanks to very small rises in CAML:Central Asia Metals and ANTO:Antofagasta, but a pretty flat week.

Not quite as bleak as the ISA chart

None of them seem capable of getting above the trend line

The trading account looks like this after week 336 overall and week 24 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£572.44	(-69.0%)	+£12.35
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£12.95	(-8.4%)	+£0.56
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.77	(1.8%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

The 0.5p rise on OPTI:Optibiotix resulted in a £12 improvement, but little hope of getting this back as a regularly changing account, not that it ever has been apart from a bout 3 weeks.

It's a long way back from here

Under the trend line but at least we haven't dragged it downwards just yet.

There was a message late on Friday to say there is a glimmer of hope for DDDD:4d Pharma. Unfortunately the rescue package will result in massive dilution, and also drop the share price from the current 14p at the point it was suspended to 6p. My holding will be worth about£1,200 after paying £18,000 for them. I'm not sure I can stomach that much of a loss, so will hang on to them in the hope something good happens. I'm hoping the transaction will be conditional on most of the board stepping down, as it was sheer incompetence that got us into this mess and it will simply continue if they are allowed to stay.

There has been no news from PBX:ProBiotix so it looks like I won't be able to sell the shares I bought before the dividend shares are tradeable and the share price collapses when ex-OPTI:Optibiotix holders sell as soon as they are able. It was a gamble, but I thought an educated one, as I was so certain good news would be published before the lock-in ended. It appears whatever I do to try and make money from microbiome shares is doomed to failure. I have to learn the lesson that there is a right time to buy shares in companies with new tech, and I failed miserably to pick it.

2022 has been a really shitty year for my portfolio. At the end of 2021 I wrote "Just one more update left for 2021 and whatever happens next week it's going to be a depressing picture for 2021. Having to write about a consistently falling portfolio for a whole year has been very depressing." and summarised with "Let's hope 2022 reverses the form of 2021, else I'll be in deep trouble."

Well, 2022 simply continued the form of 2021, and so yes, I am in deep trouble.

Is it too much to hope that 2023 will be any better?

Week 385 Review - Santa's pressie is a new all-time low

Christmas gloom deepened as the OPTI:Optibiotix share price continued to fall, and another 1.25p drop this week was the main contributor to a widening of the deficit between cost and value of £2,639 taking it to a record £119,727 and dropping portfolio value to £62,665. This is such a great way to lose loads of money!

OPTI:Optibiotix was my worst performer, dropping 7% in the trading accounts but only 2% of the cost price of my main holding. It was enough to do much of the damage this week, although most shares dropped a little.

Share of the week was the only one to rise 5% as ANTO:Antofagasta goes back into profit and is 5% up. 

Just when I thought it couldn't get any worse

We've dropped below the trend line. Great!

Here's the ISA and shares portfolio after week 21 of year 8.

			Weekly Change
Cash	£175.20		+£0
Portfolio cost	£82,003.25		+£0
Portfolio sell value (bid price-commission)	£24,025.56	(-70.7%)	-£1,340.10
Potential profits	£0		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.05		+£0
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£208.53	(-5.6%)	+£10.43
Total Dividends	£11,768.92		+£0
Total Interest	£0.05		+£0
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£433.62	(11.7%)	-£1.13
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

Not much happened other than losing £1,340

Will I have to adjust the y axis to go below £20k?

Below the trend line

The SIPP looks like this after week 369 overall and week 5 of year 8.

			Weekly Change
Cash	£639.11		+£0
Portfolio cost	£98,539.81		+£0
Portfolio sell value (bid price - commission)	£38,079.50	(-61.4%)	-£1,268.81
Potential profits	£331.40		+£101.51
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.01		+£0
Yr 8 Profit from sales	£94.41		+£0
Yr 8 projected avg monthly profit	£70.55	(1.4%)	-£17.64
Total Dividends	£14,142.78		+£0
Total Interest	£0.26		+£0
Total Profit from sales	£20,528.16		+£0
Average monthly cash profit	£395.30	(8.0%)	-£1.08
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Almost the same as the ISA, with a drop of £1,268, but a silver lining as both CAML:Central Asia Metals and ANTO:Antofagasta climb to send potential profits up by £101.

Similar story to the ISA

Also just below the trend line

The trading account looks like this after week 335 overall and week 23 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£560.09	(-69.7%)	-£30.86
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£13.51	(-8.8%)	+£0.62
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.78	(1.8%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

The drop in OPTI:Optibiotix sees this drop by £30 into even worse trouble.

That prolonged gradual recovery has well and truly reversed

The trend line still points up, but for how long?

Not only am I losing more money that at any point so far, but my entire family came down with Covid so I couldn't visit them for Christmas. Probably for the best else I'll have infected them with the vile cold that I've had. I really hope 2023 doesn't get worse than this!

Week 384 Review - Santa nowhere in sight as we plunge to a new all-time low

Yet another bad week in a month when we're supposed to get a rally. It was generally pretty flat, but a 0.75p fall in OPTI:Optibiotix made a big dent, as did the announcement of a placing by SBTX:SkinBioTherapeutics, with the deficit between cost and value widening by £1,818 to £117,087 and portfolio value dropping to £65,304. 

Worst performer on paper was my new purchase of III:3i Group as part of my monthly savings, but I only bought 9 shares so even a tiny buying commission of £1.50, when added to the selling commission of £9.95, means the £123 purchase was over 10% down as soon as I bought it. That will rectify as I add more over the next 10 months and the commission has less of an impact.

SBTX:SkinBioTherapeutics dropped 5% after announcement of a placing, so it's now pretty much at the placing price. I have subscribed for 2,500 shares as part of the retail offer, as there is no commission and I had a bit of spare cash in the accounts, plus I added a small amount because my car cost less to fix than I had budgeted for.

Share of the Week is the only big riser, with BLU:Blue Star Capital climbing 5% for no obvious reason. Still no sign of Satoshipay taking off, so not holding out much hope for these.

Even lower than last week

And what a surprise, we're back on the trend line and following it down

Here's the ISA and shares portfolio after week 20 of year 8.

			Weekly Change
Cash	£175.20		+£122.52
Portfolio cost	£82,003.25		+£0
Portfolio sell value (bid price-commission)	£25,365.66	(-69.1%)	-£817.14
Potential profits	£0		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.05		+£0.02
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£218.96	(-5.9%)	+£10.67
Total Dividends	£11,768.92		+£0
Total Interest	£0.05		+£0.02
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£434.75	(11.7%)	-£1.18
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

I added £130 to cover the SBTX:SkinBioTherapeutics subscription, and monthly fees were taken, and much excitement with 2p interest earned. Portfolio value dropped £817 which is normal in these dark times.

Desperate

Following the trend line down

The SIPP looks like this after week 368 overall and week 4 of year 8.

			Weekly Change
Cash	£639.11		+£93.65
Portfolio cost	£98,539.81		+£123.34
Portfolio sell value (bid price - commission)	£39,348.31	(-60.1%)	-£982.47
Potential profits	£229.89		-£29.78
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.01		+£0.01
Yr 8 Profit from sales	£94.41		+£0
Yr 8 projected avg monthly profit	£88.19	(1.8%)	-£48.18
Total Dividends	£14,142.78		+£0
Total Interest	£0.26		+£0.01
Total Profit from sales	£20,528.16		+£0
Average monthly cash profit	£396.38	(8.0%)	-£1.23
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

I added £100 towards the SBTX:SkinBioTherapeutics subscription, and portfolio cost went up £123 when I bought 9 share in III:3i Group at 1347.001p costing £123,34. Unfortunately they have already dropped to 1281.5p. I'll keep the monthly savings going for 10 months though, as I'll be buying cheaper each month if the price drops.

Portfolio value dropped £982, and a small drop in CAML:Central Asia Metals meant a £29 drop in potential profits, as they are now my only profitable share. The recent magic formula shares are only just in the red, so hoping a late rally next week will get them into profit.

Looks almost flat

As with the ISA, clinging to the trend line

The trading account looks like this after week 334 overall and week 22 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£590.95	(-68.0%)	-£18.52
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£14.13	(-9.2%)	+£0.67
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.79	(1.8%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

OPTI:Optibiotix continues to fall, so this account continues to be an unmitigated disaster.

I should maybe give up

We flirted above the trend line for quite a while, but it's determined to turn back downwards

It looks like there's going to be no news to save the PBX:Prebiotix Health share price when the lock-in ends, so I could easily see another £10k wiped off my portfolio at the start of the new year. It looks bad now, but it's going to get worse before it gets better. I'm also going to have no cash available when the JLP:Jubilee Metals warrant holder stops selling in January, so that will no doubt take off and I'll miss it.

It's getting harder and harder to summon up the enthusiasm to write this every week. It's just deepening my misery having to write about it. I'm hoping next week won't be another new low, so at least there will be something positive to write about at Christmas proper.

Week 383 Review - Catastrophic week obliterating recent gains and stopping out three positions

Just when I thought things were starting to recover and a Santa rally was on the way, one of the worst weeks ever as OPTI:Optibiotix do a discounted share subscription to a big investor and the share price plummets below it. Also general market misery meant three of my magic formula virtual stop-losses triggered and I had to sell. The deficit between cost and value widened by an eye-watering £10,399 to £115,269 and the value dropped to £66,999. This is the worst it has ever been. Merry Christmas!

OPTI:Optibiotix fell 4.5p to a bid price of 14.5p which contributed over £9,000 of the losses this week. It was an 8% drop in my ISA and SIPP, but a 23% drop in my trading holdings which I bought for around 19p. I can't believe a company that still looks so promising could have been such a dreadful investment.

Some of my magic formula shares dropped enough to trigger my virtual stop losses, so AJB:AJBell, PLUS:Plus500 and EMG:Man Group probably fell over 5% or thereabouts, but I don't record the weekly drop if I sell them. More detail in the SIPP review.

Share of the Week was one of my stinkers, SAE:Simec Atlantis Energy, which announced that their power storage facility has had the green light to proceed. I still think they'll go bust.

Desperate

Biggest ever deficit and back on the downward trend line

Here's the ISA and shares portfolio after week 19 of year 8.

			Weekly Change
Cash	£52.68		+£0
Portfolio cost	£82,003.25		+£0
Portfolio sell value (bid price-commission)	£26,182.80	(-68.1%)	-£4,742.24
Potential profits	£0		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.03		+£0
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£229.63	(-6.2%)	+£12.76
Total Dividends	£11,768.92		+£0
Total Interest	£0.03		+£0
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£435.93	(11.8%)	-£1.14
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

Not much happened here except OPTI:Optibiotix collapsing and contributing to the portfolio losing £4,742 in value

Very depressing

Back on the trend line and biggest ever deficit

The SIPP looks like this after week 367 overall and week 3 of year 8.

			Weekly Change
Cash	£545.46		+£450.52
Portfolio cost	£98,416.47		-£356.11
Portfolio sell value (bid price - commission)	£40,207.44	(-59.1%)	-£5,902.32
Potential profits	£259.67		-£552.20
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0		+£0
Yr 8 Profit from sales	£94.41		+£94.41
Yr 8 projected avg monthly profit	£136.37	(2.8%)	+£136.37
Total Dividends	£14,142.78		+£0
Total Interest	£0.25		+£0
Total Profit from sales	£20,528.16		+£94.41
Average monthly cash profit	£397.61	(8.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Rather a lot happened here.

First victim of my virtual stop loss rule was EMG:Man Group which went past 15% loss. I was too slow to sell NUM:Numis Corp and am now stuck with it at 34% loss, so wasn't hanging about with EMG. I sold my 371 shares at 207.45p after buying them at 236.7921p so made a loss of £134.76 (15%), but freed up £759 to re-invest.

I bought 296 shares in APAX:Apax Global Alpha at 182.332p costing £549.65. Adding these to my original holding takes it to the magic formula ideal cost of £1,063 at an average of 183.7268p. They are 5th in my new magic formula ranking system, so I figured it was right to get them up to the same level as the others. They are currently 4% down, but only 2% if you include the dividend.

The next victim of my stop loss rule was PLUS:Plus500 which was in profit, but dropped more than 10% from its high. I sold my 63 shares at 1673p after paying 1570.903p and made £97.12 (9.5%) profit. If you include dividends I made 17% profit. These are still 3rd on my magic formula ranking, so if there's a dip in price I may buy back.

Instead I invested in 69 shares of ANTO:Antofagasta at 1430.125p costing £1,003.67. They are 8th in my magic formula ranking and I'm hoping commodities will have a bit of a bounce as China drops Covid lockdowns. The only companies above them in the ranking are BHP:BHP Group which I'm avoiding due to the potential of massive fines for their burst dam disaster a few years ago, and ASHM:Ashmore Group which are heavily into Evergrande bonds, with the ongoing risk they will go bankrupt and default.

My third stop loss was sadly AJB:AJ Bell which I really liked, but they dropped below the 10% cut-off so I sold my 325 shares at 356.6568p after paying 307.1359 and made £132.05 (13.4%) profit. You can see there is a problem with this approach. I am making 15% losses on anything that drops below the cut-off, but if I'm making less than 15% profit on the ones that actually increase in value, then given there are fewer than the ones that lose, I'm never going to make any money. I could just put it down to a blip due to a really crappy market. We'll see how it pans out. I'm shocked to be seeing 10% swings in FTSE companies when you only expect that on AIM.

I used the proceeds of the sale to buy 17 shares in RIO:Rio Tinto at 5793.51p costing £1,001.77. These are only 19th in my magic formula rankings, but I bought them for the same reason I went for ANTO:Antofagasta, that China is coming out of lockdown. My rule is that I can buy any magic formula share as long as it's in the top 30, but I'll never go lower than 30th (until I do).

So my net profit from the sales was £94 and I re-invested £356 less than before, so cash is up by £450. I'm also in positive territory for year 8 which is nice, but portfolio value dropped by nearly £6,000 and potential profits by £554 as now CAML:Central Asia Metals is the only share left in the black.

As part of selling EMG:Man Group I also changed my monthly investment plan, so this coming week I'll get shares in III:3i Group which is 4th in my magic formula ranking.

Not quite lowest, but the figures fib slightly as I've added more money since I was last at this level.

That's more of an accurate picture. Biggest ever deficit and back on the dropping trend line.

The trading account looks like this after week 333 overall and week 21 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£609.47	(-67.0%)	-£111.11
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£14.80	(-9.6%)	+£0.74
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.80	(1.8%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

I could have sold OPTI:Optibitix for a profit a few weeks ago, and now it's sat on a 28% loss. Absolute bloody disaster. That drop cost £111 and one of the biggest weekly drops in this account, which is saying something when all but one of the shares are suspended!

Three months of gradual climbing obliterated in one week.

I knew it was too good to be true that I'd stay above a rising trend line. 

I can't emphasise just how pissed off I am. My portfolio has been steadily losing value for nearly two years, and everything I touch turns to shit. I finally get a couple of profitable magic formula shares and they plunge 10% in a few weeks. Every time there's a chink of light with OPTI:Optibiotix something comes along to smash it. Meanwhile the PBX:Probiotix lock-in is about to come to an end, and there's still been no news to lift the share price. Not only will I lose thousands in the value of my dividend when half the disgruntled ex-OPTI holders sell on day one, but the £1,500 I invested in anticipation of selling at a profit before the lock-in ended will be wiped out.

The only thing that could make me more depressed this Christmas would be DDDD:4D Pharma announcing they can't find a buyer and have gone bust, and I reckon there's a reasonable chance that's going to happen.

I'm going to get a beer...

Week 382 Review - AJ Bell soars but Optibiotix lets the side down again

A disappointing week, with most of last week's gains being wiped out and a bad week for microbiome companies. The deficit between cost and value widened by £4,370 to £104,869 and portfolio value dropped to £77,903.

My trading holding in OPTI:Optibiotix was the biggest loser, falling 11% and going into loss. That was just 2p which meant my main holding only dropped 3%, but it's responsible for most of this week's loss.

SBTX:SkinBioTherapeutics also had a bad week, dropping 7% as we continue to get no news whatsoever.

Share of the Week was the only one to increase by a significant amount, as AJB:AJ Bell climbed 9% after a broker buy recommendation and is now an impressive 24% up.

Only crumb of comfort was the drop wasn't bigger than last week's gain. Might be by next week though...

Right side of the trend line but way too close.

Here's the ISA and shares portfolio after week 18 of year 8.

			Weekly Change
Cash	£52.68		+£0
Portfolio cost	£82,003.25		+£0
Portfolio sell value (bid price-commission)	£30,925.04	(-62.3%)	-£2,147.23
Potential profits	£0		-£156.12
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.03		+£0
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£242.39	(-6.6%)	+£14.26
Total Dividends	£11,768.92		+£0
Total Interest	£0.03		+£0
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£437.07	(11.8%)	-£1.15
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

The OPTI:Optibiotix drop wiped out all potential profits and was responsible for most of the £2,147 loss in value.

Still rubbish

Still rubbish, but right side of the line

The SIPP looks like this after week 366 overall and week 2 of year 8.

			Weekly Change
Cash	£94.94		+£0
Portfolio cost	£98,772.58		+£0
Portfolio sell value (bid price - commission)	£46,109.76	(-53.3%)	-£2,174.11
Potential profits	£813.87		+£181.11
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0		+£0
Yr 8 Profit from sales	£0		+£0
Yr 8 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£14,142.78		+£0
Total Interest	£0.25		+£0
Total Profit from sales	£20,433.75		+£0
Average monthly cash profit	£397.58	(8.0%)	-£1.09
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Same story as the ISA for the total value, but great news for potential profits as all three profitable shares gained. I've already mentioned AJB:AJ Bell being up 24%, but PLUS:Plus500 climbed 4% to go 21% up, or 28% if you include dividends, and CAML:Central Asia Metals climbed 2% to go back to 11% up, or 15% if you include dividends. 

Some of my other magic formula shares are staging a bit of a recovery too, with CEY:Centamin up 1% and is now only 8% down, and APAX:Apax Global Alpha is only 7% down, and IGG:IG Group is only 7% down. 

The other 4 aren't so great, with EMG:Man Group down 12% and in danger of triggering the 15% virtual stop loss, NUM:Numis Corp down 35% because I was sleeping when they passed the 15% sell level, FXPO:Ferrexpo down 67% due to Ukraine war and POLY:Polymetal down 87% due to being on the wrong side in the Ukraine war.

Feels like there is still some upward momentum

Looks less promising

The trading account looks like this after week 332 overall and week 20 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£720.58	(-61.0%)	-£49.38
Potential profits	£0		-£23.26
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£15.54	(-10.1%)	+£0.82
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.81	(1.8%)	+£0
(Sold stocks profit + Dividends - Fees / Months)

All OPTI:Optibiotix profits wiped out and all my optimism crushed.

Still very depressing

Fractionally above the trend line - I can't afford to cross below it, but will next week unless OPTI:Optibiotix moves back upwards.

Hoping for a bit of a Santa rally, but previous years have been really disappointing. I've got virtual stop losses on my profitable magic formula shares to sell if they drop 10% from here, and EMG:Man Group is only 3% above my 15% loss stop-loss, which I really need to get strict with after the NUM:Numis Corp disaster.